BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deep G, Agarwal R. Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer. Cancer Metastasis Rev 2010;29:447-63. [PMID: 20714788 DOI: 10.1007/s10555-010-9237-0] [Cited by in Crossref: 149] [Cited by in F6Publishing: 138] [Article Influence: 12.4] [Reference Citation Analysis]
Number Citing Articles
1 Dalil D, Iranzadeh S, Kohansal S. Anticancer potential of cryptotanshinone on breast cancer treatment; A narrative review. Front Pharmacol 2022;13:979634. [DOI: 10.3389/fphar.2022.979634] [Reference Citation Analysis]
2 Ribeiro VR, Romao-veiga M, Nunes PR, de Oliveira LRC, Romagnoli GG, Peracoli JC, Peracoli MTS. Silibinin downregulates the expression of the Th1 and Th17 profiles by modulation of STATs and transcription factors in pregnant women with preeclampsia. International Immunopharmacology 2022;109:108807. [DOI: 10.1016/j.intimp.2022.108807] [Reference Citation Analysis]
3 Shao G, Liu Y, Lu L, Zhang G, Zhou W, Wu T, Wang L, Xu H, Ji G. The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products. Front Pharmacol 2022;13:944088. [DOI: 10.3389/fphar.2022.944088] [Reference Citation Analysis]
4 Wang H, Zhu J, Jia Z, Lu S. Pretreatment of diabetic aged rats with combination of ginsenoside-Mc1 and silibinin protects liver from ischemia-reperfusion injury through an AMPK-dependent mechanism. Turkish Journal of Biochemistry 2022;47:23-32. [DOI: 10.1515/tjb-2021-0010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Salvoza N, Giraudi PJ, Tiribelli C, Rosso N. Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates. Int J Mol Sci 2022;23:2764. [PMID: 35269912 DOI: 10.3390/ijms23052764] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Koltai T, Fliegel L. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. J Evid Based Integr Med 2022;27:2515690X211068826. [PMID: 35018864 DOI: 10.1177/2515690X211068826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhai K, Mazurakova A, Koklesova L, Kubatka P, Büsselberg D. Flavonoids Synergistically Enhance the Anti-Glioblastoma Effects of Chemotherapeutic Drugs. Biomolecules 2021;11:1841. [PMID: 34944485 DOI: 10.3390/biom11121841] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Tobeiha M, Rajabi A, Raisi A, Mohajeri M, Yazdi SM, Davoodvandi A, Aslanbeigi F, Vaziri M, Hamblin MR, Mirzaei H. Potential of natural products in osteosarcoma treatment: Focus on molecular mechanisms. Biomed Pharmacother 2021;144:112257. [PMID: 34688081 DOI: 10.1016/j.biopha.2021.112257] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Addeo R. Silibinin: A New Opportunity for the Treatment of Brain Metastasis from Lung Cancer. J Exp Pharmacol 2021;13:901-3. [PMID: 34611448 DOI: 10.2147/JEP.S326871] [Reference Citation Analysis]
10 Medeiros M, Candido MF, Valera ET, Brassesco MS. The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors? Cell Mol Life Sci 2021. [PMID: 34333711 DOI: 10.1007/s00018-021-03906-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Habán M, Zvercová D, Adamjaková M. Evaluation of variability of silymarin complex in Silybi mariani fructus harvested during two production years. European Pharmaceutical Journal 2021;68:40-5. [DOI: 10.2478/afpuc-2020-0023] [Reference Citation Analysis]
12 Huo M, Wang H, Li L, Tong Y, Hu C, Gu Y, Liu J, Yin T. Redox-sensitive hyaluronic acid-cholesterol nanovehicles potentiate efficient transmembrane internalization and controlled release for penetrated "full-line" inhibition of pre-metastatic initiation. J Control Release 2021;336:89-104. [PMID: 34119559 DOI: 10.1016/j.jconrel.2021.06.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Antal DS, Ardelean F, Avram S, Pavel IZ, Danciu C, Soica C, Dehelean C. Flavonolignans: One Step Further in the Broad-Spectrum Approach of Cancer. Anticancer Agents Med Chem 2020;20:1817-30. [PMID: 31976848 DOI: 10.2174/1871520620666200124112649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Rathaur P, Soni MN, Gelat B, Rawal R, Pandya HA, Johar K. Network pharmacology-based evaluation of natural compounds with paclitaxel for the treatment of metastatic breast cancer. Toxicol Appl Pharmacol 2021;423:115576. [PMID: 34000264 DOI: 10.1016/j.taap.2021.115576] [Reference Citation Analysis]
15 Kalhori MR, Khodayari H, Khodayari S, Vesovic M, Jackson G, Farzaei MH, Bishayee A. Regulation of Long Non-Coding RNAs by Plant Secondary Metabolites: A Novel Anticancer Therapeutic Approach. Cancers (Basel) 2021;13:1274. [PMID: 33805687 DOI: 10.3390/cancers13061274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
16 Tuli HS, Mittal S, Aggarwal D, Parashar G, Parashar NC, Upadhyay SK, Barwal TS, Jain A, Kaur G, Savla R, Sak K, Kumar M, Varol M, Iqubal A, Sharma AK. Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance. Semin Cancer Biol 2021;73:196-218. [PMID: 33130037 DOI: 10.1016/j.semcancer.2020.09.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
17 Mashhadi Akbar Boojar M, Mashhadi Akbar Boojar M, Golmohammad S. Overview of Silibinin anti-tumor effects. Journal of Herbal Medicine 2020;23:100375. [DOI: 10.1016/j.hermed.2020.100375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Islam SU, Ahmed MB, Ahsan H, Islam M, Shehzad A, Sonn JK, Lee YS. An Update on the Role of Dietary Phytochemicals in Human Skin Cancer: New Insights into Molecular Mechanisms. Antioxidants (Basel) 2020;9:E916. [PMID: 32993035 DOI: 10.3390/antiox9100916] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
19 Jiang Y, Song H, Jiang L, Qiao Y, Yang D, Wang D, Li J. Silybin Prevents Prostate Cancer by Inhibited the ALDH1A1 Expression in the Retinol Metabolism Pathway. Front Cell Dev Biol 2020;8:574394. [PMID: 32984354 DOI: 10.3389/fcell.2020.574394] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
20 Lashgarian HE, Adamii V, Ghorbanzadeh V, Chodari L, Kamali F, Akbari S, Dariushnejad H. Silibinin Inhibit Cell Migration through Downregulation of RAC1 Gene Expression in Highly Metastatic Breast Cancer Cell Line. Drug Res (Stuttg) 2020;70:478-83. [PMID: 32791535 DOI: 10.1055/a-1223-1734] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Liu Y, Xie X, Hou X, Shen J, Shi J, Chen H, He Y, Wang Z, Feng N. Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis. J Nanobiotechnology 2020;18:83. [PMID: 32473632 DOI: 10.1186/s12951-020-00638-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
22 Huo M, Wang H, Zhang Y, Cai H, Zhang P, Li L, Zhou J, Yin T. Co-delivery of silybin and paclitaxel by dextran-based nanoparticles for effective anti-tumor treatment through chemotherapy sensitization and microenvironment modulation. Journal of Controlled Release 2020;321:198-210. [DOI: 10.1016/j.jconrel.2020.02.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 31] [Article Influence: 9.5] [Reference Citation Analysis]
23 You Y, He Q, Lu H, Zhou X, Chen L, Liu H, Lu Z, Liu D, Liu Y, Zuo D, Fu X, Kwan H, Zhao X. Silibinin Induces G2/M Cell Cycle Arrest by Activating Drp1-Dependent Mitochondrial Fission in Cervical Cancer. Front Pharmacol 2020;11:271. [PMID: 32226384 DOI: 10.3389/fphar.2020.00271] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
24 Prasad RR, Paudel S, Raina K, Agarwal R. Silibinin and non-melanoma skin cancers. J Tradit Complement Med 2020;10:236-44. [PMID: 32670818 DOI: 10.1016/j.jtcme.2020.02.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
25 Sun LR, Zhou W, Zhang HM, Guo QS, Yang W, Li BJ, Sun ZH, Gao SH, Cui RJ. Modulation of Multiple Signaling Pathways of the Plant-Derived Natural Products in Cancer. Front Oncol 2019;9:1153. [PMID: 31781485 DOI: 10.3389/fonc.2019.01153] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
26 Sajjadi M, Karimi E, Oskoueian E, Iranshahi M, Neamati A. Galbanic acid: Induced antiproliferation in estrogen receptor‐negative breast cancer cells and enhanced cellular redox state in the human dermal fibroblasts. J Biochem Mol Toxicol 2019;33. [DOI: 10.1002/jbt.22402] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
27 Takke A, Shende P. Nanotherapeutic silibinin: An insight of phytomedicine in healthcare reformation. Nanomedicine: Nanotechnology, Biology and Medicine 2019;21:102057. [DOI: 10.1016/j.nano.2019.102057] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
28 Yang Z, Pan Q, Zhang D, Chen J, Qiu Y, Chen X, Zheng F, Lin F. Silibinin restores the sensitivity of cisplatin and taxol in A2780-resistant cell and reduces drug-induced hepatotoxicity. Cancer Manag Res 2019;11:7111-22. [PMID: 31440098 DOI: 10.2147/CMAR.S201341] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
29 Song KA, Faber AC. Epithelial-to-mesenchymal transition and drug resistance: transitioning away from death. J Thorac Dis 2019;11:E82-5. [PMID: 31372302 DOI: 10.21037/jtd.2019.06.11] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
30 Mirzaaghaei S, Foroughmand AM, Saki G, Shafiei M. Combination of Epigallocatechin-3-gallate and Silibinin: A Novel Approach for Targeting Both Tumor and Endothelial Cells. ACS Omega 2019;4:8421-30. [PMID: 31459931 DOI: 10.1021/acsomega.9b00224] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
31 Zappavigna S, Vanacore D, Lama S, Potenza N, Russo A, Ferranti P, Dallio M, Federico A, Loguercio C, Sperlongano P, Caraglia M, Stiuso P. Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells. Int J Mol Sci 2019;20:E2190. [PMID: 31058823 DOI: 10.3390/ijms20092190] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
32 Solís-gómez A, Sato-berrú R, Mata-zamora M, Saniger J, Guirado-lópez R. Characterizing the properties of anticancer silibinin and silybin B complexes with UV–Vis, FT-IR, and Raman spectroscopies: A combined experimental and theoretical study. Journal of Molecular Structure 2019;1182:109-18. [DOI: 10.1016/j.molstruc.2019.01.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
33 Fontana F, Raimondi M, Marzagalli M, Sommariva M, Limonta P, Gagliano N. Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells. Cells 2019;8:E143. [PMID: 30754655 DOI: 10.3390/cells8020143] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
34 Iqbal J, Abbasi BA, Ahmad R, Batool R, Mahmood T, Ali B, Khalil AT, Kanwal S, Afzal Shah S, Alam MM, Bashir S, Badshah H, Munir A. Potential phytochemicals in the fight against skin cancer: Current landscape and future perspectives. Biomedicine & Pharmacotherapy 2019;109:1381-93. [DOI: 10.1016/j.biopha.2018.10.107] [Cited by in Crossref: 34] [Cited by in F6Publishing: 42] [Article Influence: 11.3] [Reference Citation Analysis]
35 Romanucci V, Di Fabio G, Zarrelli A. A New Class of Synthetic Flavonolignan-Like Dimers: Still Few Molecules, but with Attractive Properties. Molecules 2018;24:E108. [PMID: 30597952 DOI: 10.3390/molecules24010108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
36 Rajalakshmi S, Vimalraj S, Saravanan S, Raj Preeth D, Shairam M, Anuradha D. Synthesis and characterization of silibinin/phenanthroline/neocuproine copper(II) complexes for augmenting bone tissue regeneration: an in vitro analysis. J Biol Inorg Chem 2018;23:753-62. [DOI: 10.1007/s00775-018-1566-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
37 Mao J, Yang H, Cui T, Pan P, Kabir N, Chen D, Ma J, Chen X, Chen Y, Yang Y. Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT. Eur J Pharmacol 2018;832:39-49. [PMID: 29782854 DOI: 10.1016/j.ejphar.2018.05.027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
38 Zhang X, Liu J, Zhang P, Dai L, Wu Z, Wang L, Cao M, Jiang J. Silibinin induces G1 arrest, apoptosis and JNK/SAPK upregulation in SW1990 human pancreatic cancer cells. Oncol Lett 2018;15:9868-76. [PMID: 29805688 DOI: 10.3892/ol.2018.8541] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
39 Safarpoor M, Ghaedi M, Asfaram A, Yousefi-nejad M, Javadian H, Zare Khafri H, Bagherinasab M. Ultrasound-assisted extraction of antimicrobial compounds from Thymus daenensis and Silybum marianum: Antimicrobial activity with and without the presence of natural silver nanoparticles. Ultrasonics Sonochemistry 2018;42:76-83. [DOI: 10.1016/j.ultsonch.2017.11.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
40 Bai ZL, Tay V, Guo SZ, Ren J, Shu MG. Silibinin Induced Human Glioblastoma Cell Apoptosis Concomitant with Autophagy through Simultaneous Inhibition of mTOR and YAP. Biomed Res Int 2018;2018:6165192. [PMID: 29780826 DOI: 10.1155/2018/6165192] [Cited by in Crossref: 15] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
41 Ng CY, Yen H, Hsiao HY, Su SC. Phytochemicals in Skin Cancer Prevention and Treatment: An Updated Review. Int J Mol Sci 2018;19:E941. [PMID: 29565284 DOI: 10.3390/ijms19040941] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
42 Han L, Guo K, Gu F, Zhang YF, Li K, Mu XX, Liu HJ, Zhou XD, Luo W. Effects of silibinin-loaded thermosensitive liposome-microbubble complex on inhibiting rabbit liver VX2 tumors in sub-hyperthermia fields. Exp Ther Med 2018;15:1233-40. [PMID: 29434709 DOI: 10.3892/etm.2017.5566] [Reference Citation Analysis]
43 Romanucci V, Agarwal C, Agarwal R, Pannecouque C, Iuliano M, De Tommaso G, Caruso T, Di Fabio G, Zarrelli A. Silibinin phosphodiester glyco-conjugates: Synthesis, redox behaviour and biological investigations. Bioorg Chem 2018;77:349-59. [PMID: 29421711 DOI: 10.1016/j.bioorg.2018.01.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
44 Bosch-Barrera J, Sais E, Cañete N, Marruecos J, Cuyàs E, Izquierdo A, Porta R, Haro M, Brunet J, Pedraza S, Menendez JA. Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin. Oncotarget 2016;7:32006-14. [PMID: 26959886 DOI: 10.18632/oncotarget.7900] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
45 Fatehi D, Mohammadi M, Shekarchi B, Shabani A, Seify M, Rostamzadeh A. Radioprotective effects of Silymarin on the sperm parameters of NMRI mice irradiated with γ-rays. J Photochem Photobiol B 2018;178:489-95. [PMID: 29232573 DOI: 10.1016/j.jphotobiol.2017.12.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
46 Jana S, Jana J, Patra K, Mondal S, Bhat J, Sarkar A, Sengupta P, Biswas A, Mukherjee M, Tripathi SP, Gangwal R, Hazra J, Sangamwar AT, Mukherjee G, Bhattacharjee S, Mandal DP, Chatterjee S. LINCRNA00273 promotes cancer metastasis and its G-Quadruplex promoter can serve as a novel target to inhibit cancer invasiveness. Oncotarget 2017;8:110234-56. [PMID: 29299144 DOI: 10.18632/oncotarget.22622] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
47 Kuen CY, Fakurazi S, Othman SS, Masarudin MJ. Increased Loading, Efficacy and Sustained Release of Silibinin, a Poorly Soluble Drug Using Hydrophobically-Modified Chitosan Nanoparticles for Enhanced Delivery of Anticancer Drug Delivery Systems. Nanomaterials (Basel) 2017;7:E379. [PMID: 29117121 DOI: 10.3390/nano7110379] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
48 Miethe C, Nix H, Martin R, Hernandez AR, Price RS. Silibinin Reduces the Impact of Obesity on Invasive Liver Cancer. Nutrition and Cancer 2017;69:1272-80. [DOI: 10.1080/01635581.2017.1367935] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
49 Catanzaro D, Gabbia D, Cocetta V, Biagi M, Ragazzi E, Montopoli M, Carrara M. Silybin counteracts doxorubicin resistance by inhibiting GLUT1 expression. Fitoterapia 2018;124:42-8. [PMID: 29031537 DOI: 10.1016/j.fitote.2017.10.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
50 Marin V, Gazzin S, Gambaro SE, Dal Ben M, Calligaris S, Anese M, Raseni A, Avellini C, Giraudi PJ, Tiribelli C, Rosso N. Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic Steatohepatitis. Nutrients 2017;9:E1006. [PMID: 28895929 DOI: 10.3390/nu9091006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
51 Gogoi P, Das MK, Ramteke A, Maji TK. Soy flour–ZnO nanoparticles for controlled release of silibinin: Effect of ZnO nanoparticle, surfactant, and cross-linker. International Journal of Polymeric Materials and Polymeric Biomaterials 2018;67:543-52. [DOI: 10.1080/00914037.2017.1354200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
52 Zheng W, Feng Z, Lou Y, Chen C, Zhang C, Tao Z, Li H, Cheng L, Ying X. Silibinin protects against osteoarthritis through inhibiting the inflammatory response and cartilage matrix degradation in vitro and in vivo. Oncotarget 2017;8:99649-65. [PMID: 29245931 DOI: 10.18632/oncotarget.20587] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
53 Belli V, Sforza V, Cardone C, Martinelli E, Barra G, Matrone N, Napolitano S, Morgillo F, Tuccillo C, Federico A, Dallio M, Loguercio C, Gravina AG, De Palma R, Ciardiello F, Troiani T. Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer. Oncotarget 2017;8:68305-16. [PMID: 28978118 DOI: 10.18632/oncotarget.20054] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
54 Amawi H, Hussein NA, Karthikeyan C, Manivannan E, Wisner A, Williams FE, Samuel T, Trivedi P, Ashby CR Jr, Tiwari AK. HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity Studies. Front Pharmacol 2017;8:498. [PMID: 28824426 DOI: 10.3389/fphar.2017.00498] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
55 Sokolová R, Kocábová J, Marhol P, Fiedler J, Biedermann D, Vacek J, Křen V. Oxidation of Natural Bioactive Flavonolignan 2,3-Dehydrosilybin: An Electrochemical and Spectral Study. J Phys Chem B 2017;121:6841-6. [DOI: 10.1021/acs.jpcb.7b04651] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
56 Marzban M, Anjamshoa M, Jafari P, Masoumi H, Ahadi R, Fatehi D. Effects of gamma rays on rat testis tissue according to the morphological parameters and immunohistochemistry: radioprotective role of silymarin. Electron Physician 2017;9:4524-32. [PMID: 28848626 DOI: 10.19082/4524] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
57 Amawi H, Ashby CR Jr, Tiwari AK. Cancer chemoprevention through dietary flavonoids: what's limiting? Chin J Cancer 2017;36:50. [PMID: 28629389 DOI: 10.1186/s40880-017-0217-4] [Cited by in Crossref: 70] [Cited by in F6Publishing: 79] [Article Influence: 14.0] [Reference Citation Analysis]
58 Yazdi Rouholamini SE, Moghassemi S, Maharat Z, Hakamivala A, Kashanian S, Omidfar K. Effect of silibinin-loaded nano-niosomal coated with trimethyl chitosan on miRNAs expression in 2D and 3D models of T47D breast cancer cell line. Artificial Cells, Nanomedicine, and Biotechnology 2018;46:524-35. [DOI: 10.1080/21691401.2017.1326928] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
59 Ramos-Silva A, Tavares-Carreón F, Figueroa M, De la Torre-Zavala S, Gastelum-Arellanez A, Rodríguez-García A, Galán-Wong LJ, Avilés-Arnaut H. Anticancer potential of Thevetia peruviana fruit methanolic extract. BMC Complement Altern Med 2017;17:241. [PMID: 28464893 DOI: 10.1186/s12906-017-1727-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
60 Chávez G, Campos CH, Jiménez VA, Torres CC, Díaz C, Salas G, Guzmán L, Alderete JB. Polyamido amine (PAMAM)-grafted magnetic nanotubes as emerging platforms for the delivery and sustained release of silibinin. J Mater Sci 2017;52:9269-81. [DOI: 10.1007/s10853-017-1140-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
61 AbouZid SF, Ahmed HS, Moawad AS, Owis AI, Chen SN, Nachtergael A, McAlpine JB, Brent Friesen J, Pauli GF. Chemotaxonomic and biosynthetic relationships between flavonolignans produced by Silybum marianum populations. Fitoterapia 2017;119:175-84. [PMID: 28392269 DOI: 10.1016/j.fitote.2017.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
62 Ezhilarasan D, Evraerts J, Sid B, Calderon PB, Karthikeyan S, Sokal E, Najimi M. Silibinin induces hepatic stellate cell cycle arrest via enhancing p53/p27 and inhibiting Akt downstream signaling protein expression. Hepatobiliary & Pancreatic Diseases International 2017;16:80-7. [DOI: 10.1016/s1499-3872(16)60166-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
63 Pearlman RL, Montes de Oca MK, Pal HC, Afaq F. Potential therapeutic targets of epithelial-mesenchymal transition in melanoma. Cancer Lett 2017;391:125-40. [PMID: 28131904 DOI: 10.1016/j.canlet.2017.01.029] [Cited by in Crossref: 61] [Cited by in F6Publishing: 86] [Article Influence: 12.2] [Reference Citation Analysis]
64 Amirsaadat S, Pilehvar-soltanahmadi Y, Zarghami F, Alipour S, Ebrahimnezhad Z, Zarghami N. Silibinin-loaded magnetic nanoparticles inhibit hTERT gene expression and proliferation of lung cancer cells. Artificial Cells, Nanomedicine, and Biotechnology 2017;45:1649-56. [DOI: 10.1080/21691401.2016.1276922] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
65 Dadras P, Atyabi F, Irani S, Ma'mani L, Foroumadi A, Mirzaie ZH, Ebrahimi M, Dinarvand R. Formulation and evaluation of targeted nanoparticles for breast cancer theranostic system. European Journal of Pharmaceutical Sciences 2017;97:47-54. [DOI: 10.1016/j.ejps.2016.11.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
66 Neri G, Micale N, Scala A, Fazio E, Mazzaglia A, Mineo PG, Montesi M, Panseri S, Tampieri A, Grassi G, Piperno A. Silibinin-conjugated graphene nanoplatform: Synthesis, characterization and biological evaluation. FlatChem 2017;1:34-41. [DOI: 10.1016/j.flatc.2016.10.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
67 Momtaz S, Niaz K, Maqbool F, Abdollahi M, Rastrelli L, Nabavi SM. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma: STAT3 targeting by polyphenols. BioFactors 2017;43:347-70. [DOI: 10.1002/biof.1345] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
68 Polachi N, Bai G, Li T, Chu Y, Wang X, Li S, Gu N, Wu J, Li W, Zhang Y, Zhou S, Sun H, Liu C. Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer – A comprehensive review. European Journal of Medicinal Chemistry 2016;123:577-95. [DOI: 10.1016/j.ejmech.2016.07.070] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
69 Deep G, Kumar R, Nambiar DK, Jain AK, Ramteke AM, Serkova NJ, Agarwal C, Agarwal R. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics. Mol Carcinog 2017;56:833-48. [PMID: 27533043 DOI: 10.1002/mc.22537] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
70 Biler M, Trouillas P, Biedermann D, Křen V, Kubala M. Tunable optical properties of silymarin flavonolignans. Journal of Photochemistry and Photobiology A: Chemistry 2016;328:154-62. [DOI: 10.1016/j.jphotochem.2016.05.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
71 Kiyama R. Biological effects induced by estrogenic activity of lignans. Trends in Food Science & Technology 2016;54:186-96. [DOI: 10.1016/j.tifs.2016.06.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
72 Sokolová R, Tarábek J, Papoušková B, Kocábová J, Fiedler J, Vacek J, Marhol P, Vavříková E, Křen V. Oxidation of the Flavonolignan Silybin. In situ EPR Evidence of the Spin-Trapped Silybin Radical. Electrochimica Acta 2016;205:118-23. [DOI: 10.1016/j.electacta.2016.04.107] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
73 Tewari-Singh N, Agarwal R. Mustard vesicating agent-induced toxicity in the skin tissue and silibinin as a potential countermeasure. Ann N Y Acad Sci 2016;1374:184-92. [PMID: 27326543 DOI: 10.1111/nyas.13099] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
74 Goswami DG, Tewari-Singh N, Agarwal R. Corneal toxicity induced by vesicating agents and effective treatment options. Ann N Y Acad Sci 2016;1374:193-201. [PMID: 27327041 DOI: 10.1111/nyas.13121] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
75 Nguyen M, Yu H, Dong B, Hadinoto K. A supersaturating delivery system of silibinin exhibiting high payload achieved by amorphous nano-complexation with chitosan. European Journal of Pharmaceutical Sciences 2016;89:163-71. [DOI: 10.1016/j.ejps.2016.04.036] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
76 Ezhilarasan D, Evraerts J, Brice S, Buc-Calderon P, Karthikeyan S, Sokal E, Najimi M. Silibinin Inhibits Proliferation and Migration of Human Hepatic Stellate LX-2 Cells. J Clin Exp Hepatol 2016;6:167-74. [PMID: 27746612 DOI: 10.1016/j.jceh.2016.01.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
77 Beydogan AB, Bolkent S. The effects of silibin administration for different time periods on mouse liver with Ehrlich ascites carcinoma. Pharmacol Rep 2016;68:543-9. [PMID: 26891241 DOI: 10.1016/j.pharep.2015.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
78 Williams C, DiLeo A, Niv Y, Gustafsson JÅ. Estrogen receptor beta as target for colorectal cancer prevention. Cancer Lett 2016;372:48-56. [PMID: 26708506 DOI: 10.1016/j.canlet.2015.12.009] [Cited by in Crossref: 80] [Cited by in F6Publishing: 94] [Article Influence: 11.4] [Reference Citation Analysis]
79 Chakrabarti M, Ray SK. Synergistic anti-tumor actions of luteolin and silibinin prevented cell migration and invasion and induced apoptosis in glioblastoma SNB19 cells and glioblastoma stem cells. Brain Research 2015;1629:85-93. [DOI: 10.1016/j.brainres.2015.10.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
80 Nambiar DK, Rajamani P, Deep G, Jain AK, Agarwal R, Singh RP. Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling. Mol Cancer Ther 2015;14:2722-34. [PMID: 26516160 DOI: 10.1158/1535-7163.MCT-15-0348] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
81 Momeny M, Ghasemi R, Valenti G, Miranda M, Zekri A, Zarrinrad G, Javadikooshesh S, Yaghmaie M, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway. Tumor Biol 2016;37:3913-23. [DOI: 10.1007/s13277-015-4220-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
82 Nambiar DK, Deep G, Singh RP, Agarwal C, Agarwal R. Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1. Oncotarget 2014;5:10017-33. [PMID: 25294820 DOI: 10.18632/oncotarget.2488] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
83 Lovelace ES, Wagoner J, MacDonald J, Bammler T, Bruckner J, Brownell J, Beyer RP, Zink EM, Kim YM, Kyle JE, Webb-Robertson BJ, Waters KM, Metz TO, Farin F, Oberlies NH, Polyak SJ. Silymarin Suppresses Cellular Inflammation By Inducing Reparative Stress Signaling. J Nat Prod 2015;78:1990-2000. [PMID: 26186142 DOI: 10.1021/acs.jnatprod.5b00288] [Cited by in Crossref: 24] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
84 Kalemci S, Topal Y, Celik SY, Yilmaz N, Beydilli H, Kosar MI, Dirican N, Altuntas I. Silibinin attenuates methotrexate-induced pulmonary injury by targeting oxidative stress. Exp Ther Med 2015;10:503-7. [PMID: 26622344 DOI: 10.3892/etm.2015.2542] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
85 Mastron JK, Siveen KS, Sethi G, Bishayee A. Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review. Anti-Cancer Drugs 2015;26:475-86. [DOI: 10.1097/cad.0000000000000211] [Cited by in Crossref: 49] [Cited by in F6Publishing: 63] [Article Influence: 7.0] [Reference Citation Analysis]
86 Blaylock RL. Methodological problems with population cancer studies: The forgotten confounding factors. Surg Neurol Int 2015;6:93. [PMID: 26097772 DOI: 10.4103/2152-7806.157893] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
87 Deep G, Kumar R, Jain AK, Agarwal C, Agarwal R. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling. Mutat Res 2014;768:35-46. [PMID: 25285031 DOI: 10.1016/j.mrfmmm.2014.05.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
88 Bosch-Barrera J, Menendez JA. Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy. Cancer Treat Rev. 2015;41:540-546. [PMID: 25944486 DOI: 10.1016/j.ctrv.2015.04.008] [Cited by in Crossref: 80] [Cited by in F6Publishing: 85] [Article Influence: 11.4] [Reference Citation Analysis]
89 Prajapati V, Kale RK, Singh RP. Silibinin Combination with Arsenic Strongly Inhibits Survival and Invasiveness of Human Prostate Carcinoma Cells. Nutrition and Cancer 2015;67:647-58. [DOI: 10.1080/01635581.2015.1019635] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
90 Bhatia V, Falzon M. Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells. Cancer Lett. 2015;362:199-207. [PMID: 25846868 DOI: 10.1016/j.canlet.2015.03.042] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
91 Cheng S, Castillo V, Eliaz I, Sliva D. Honokiol suppresses metastasis of renal cell carcinoma by targeting KISS1/KISS1R signaling. Int J Oncol 2015;46:2293-8. [PMID: 25846316 DOI: 10.3892/ijo.2015.2950] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
92 Ahmad A, Ginnebaugh KR, Li Y, Padhye SB, Sarkar FH. Molecular targets of naturopathy in cancer research: bridge to modern medicine. Nutrients. 2015;7:321-334. [PMID: 25569626 DOI: 10.3390/nu7010321] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
93 Xie Z, Ding SQ, Shen YF. Silibinin activates AMP-activated protein kinase to protect neuronal cells from oxygen and glucose deprivation-re-oxygenation. Biochem Biophys Res Commun 2014;454:313-9. [PMID: 25450395 DOI: 10.1016/j.bbrc.2014.10.080] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
94 Gohulkumar M, Gurushankar K, Rajendra Prasad N, Krishnakumar N. Enhanced cytotoxicity and apoptosis-induced anticancer effect of silibinin-loaded nanoparticles in oral carcinoma (KB) cells. Materials Science and Engineering: C 2014;41:274-82. [DOI: 10.1016/j.msec.2014.04.056] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
95 Chen YH, Chen CL, Liang CM, Liang JB, Tai MC, Chang YH, Lu DW, Chen JT. Silibinin inhibits ICAM-1 expression via regulation of N-linked and O-linked glycosylation in ARPE-19 cells. Biomed Res Int 2014;2014:701395. [PMID: 25032222 DOI: 10.1155/2014/701395] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
96 Ho BY, Lin CH, Apaya MK, Chao WW, Shyur LF. Silibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in Mice. J Tradit Complement Med 2012;2:301-11. [PMID: 24716145 DOI: 10.1016/s2225-4110(16)30116-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
97 Gándara L, Sandes E, Di Venosa G, Prack Mc Cormick B, Rodriguez L, Mamone L, Batlle A, Eiján A, Casas A. The natural flavonoid silybin improves the response to Photodynamic Therapy of bladder cancer cells. Journal of Photochemistry and Photobiology B: Biology 2014;133:55-64. [DOI: 10.1016/j.jphotobiol.2014.03.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
98 Deep G, Jain AK, Ramteke A, Ting H, Vijendra KC, Gangar SC, Agarwal C, Agarwal R. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin. Mol Cancer. 2014;13:37. [PMID: 24565133 DOI: 10.1186/1476-4598-13-37] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 6.5] [Reference Citation Analysis]
99 Ding Q, Bao J, Zhao W, Hu Y, Lu J, Chen X. Natural autophagy regulators in cancer therapy: a review. Phytochem Rev 2015;14:137-54. [DOI: 10.1007/s11101-014-9339-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
100 Grillo C, Chichiarelli S, Gaucci E, Altieri F, Turano C, Cervoni L. The binding of silibinin to ERp57. Chem Biol Interact 2014;213:37-43. [PMID: 24530445 DOI: 10.1016/j.cbi.2014.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
101 Deep G, Agarwal R. Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy. Curr Cancer Drug Targets 2013;13:486-99. [PMID: 23617249 DOI: 10.2174/15680096113139990041] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
102 El-elimat T, Raja HA, Graf TN, Faeth SH, Cech NB, Oberlies NH. Flavonolignans from Aspergillus iizukae , a Fungal Endophyte of Milk Thistle ( Silybum marianum ). J Nat Prod 2014;77:193-9. [DOI: 10.1021/np400955q] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 7.5] [Reference Citation Analysis]
103 He Q, Shi J. MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition. Adv Mater 2014;26:391-411. [PMID: 24142549 DOI: 10.1002/adma.201303123] [Cited by in Crossref: 344] [Cited by in F6Publishing: 351] [Article Influence: 43.0] [Reference Citation Analysis]
104 Mateen S, Raina K, Agarwal R. Chemopreventive and anti-cancer efficacy of silibinin against growth and progression of lung cancer. Nutr Cancer. 2013;65:3-11. [PMID: 23682778 DOI: 10.1080/01635581.2013.785004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
105 Ting H, Deep G, Agarwal C, Agarwal R. The strategies to control prostate cancer by chemoprevention approaches. Mutat Res 2014;760:1-15. [PMID: 24389535 DOI: 10.1016/j.mrfmmm.2013.12.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
106 Eissa T, Palomino O, Carretero M, Gómez-serranillos M. Ethnopharmacological study of medicinal plants used in the treatment of CNS disorders in Sinai Peninsula, Egypt. Journal of Ethnopharmacology 2014;151:317-32. [DOI: 10.1016/j.jep.2013.10.041] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
107 Zhang S, Yang Y, Liang Z, Duan W, Yang J, Yan J, Wang N, Feng W, Ding M, Nie Y, Jin Z. Silybin-mediated inhibition of Notch signaling exerts antitumor activity in human hepatocellular carcinoma cells. PLoS One 2013;8:e83699. [PMID: 24386256 DOI: 10.1371/journal.pone.0083699] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
108 Ghasemi R, Ghaffari SH, Momeny M, Pirouzpanah S, Yousefi M, Malehmir M, Alimoghaddam K, Ghavamzadeh A. Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells. Nutr Cancer. 2013;65:590-599. [PMID: 23659451 DOI: 10.1080/01635581.2013.770043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
109 van Wenum E, Jurczakowski R, Litwinienko G. Media Effects on the Mechanism of Antioxidant Action of Silybin and 2,3-Dehydrosilybin: Role of the Enol Group. J Org Chem 2013;78:9102-12. [DOI: 10.1021/jo401296k] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
110 Wu K, Ning Z, Zeng J, Fan J, Zhou J, Zhang T, Zhang L, Chen Y, Gao Y, Wang B, Guo P, Li L, Wang X, He D. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness. Cell Signal 2013;25:2625-33. [PMID: 24012496 DOI: 10.1016/j.cellsig.2013.08.028] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 7.1] [Reference Citation Analysis]
111 Xu P, Yin Q, Shen J, Chen L, Yu H, Zhang Z, Li Y. Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS. International Journal of Pharmaceutics 2013;454:21-30. [DOI: 10.1016/j.ijpharm.2013.06.053] [Cited by in Crossref: 79] [Cited by in F6Publishing: 76] [Article Influence: 8.8] [Reference Citation Analysis]
112 Althagafy HS, Meza-Aviña ME, Oberlies NH, Croatt MP. Mechanistic study of the biomimetic synthesis of flavonolignan diastereoisomers in milk thistle. J Org Chem 2013;78:7594-600. [PMID: 23876147 DOI: 10.1021/jo4011377] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
113 Ji M, Shi Y, Xu J, Lin X, Lin J. Recombinant snake venom metalloproteinase inhibitor BJ46A inhibits invasion and metastasis of B16F10 and MHCC97H cells through reductions of matrix metalloproteinases 2 and 9 activities. Anti-Cancer Drugs 2013;24:461-72. [DOI: 10.1097/cad.0b013e32835f258d] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
114 Althagafy HS, Graf TN, Sy-Cordero AA, Gufford BT, Paine MF, Wagoner J, Polyak SJ, Croatt MP, Oberlies NH. Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-O-methylated analogues of flavonolignans from milk thistle. Bioorg Med Chem 2013;21:3919-26. [PMID: 23673225 DOI: 10.1016/j.bmc.2013.04.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
115 Yang X, Li X, An L, Bai B, Chen J. Silibinin induced the apoptosis of Hep-2 cells via oxidative stress and down-regulating survivin expression. Eur Arch Otorhinolaryngol 2013;270:2289-97. [PMID: 23580032 DOI: 10.1007/s00405-013-2444-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
116 Agarwal C, Wadhwa R, Deep G, Biedermann D, Gažák R, Křen V, Agarwal R. Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship. PLoS One 2013;8:e60074. [PMID: 23555889 DOI: 10.1371/journal.pone.0060074] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
117 Polyak SJ, Ferenci P, Pawlotsky JM. Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection. Hepatology 2013;57:1262-71. [PMID: 23213025 DOI: 10.1002/hep.26179] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 8.7] [Reference Citation Analysis]
118 Narayanapillai S, Agarwal C, Deep G, Agarwal R. Silibinin inhibits ultraviolet B radiation-induced DNA-damage and apoptosis by enhancing interleukin-12 expression in JB6 cells and SKH-1 hairless mouse skin. Mol Carcinog 2014;53:471-9. [PMID: 23359305 DOI: 10.1002/mc.22000] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
119 Sy-Cordero AA, Day CS, Oberlies NH. Absolute configuration of isosilybin A by X-ray crystallography of the heavy atom analogue 7-(4-Bromobenzoyl)isosilybin A. J Nat Prod 2012;75:1879-81. [PMID: 23116206 DOI: 10.1021/np3005369] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
120 Kavitha CV, Deep G, Gangar SC, Jain AK, Agarwal C, Agarwal R. Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, and AP-1 activation in RAW264.7 cells. Mol Carcinog 2014;53:169-80. [PMID: 23115104 DOI: 10.1002/mc.21959] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
121 Nabavi SM, sureda A, Nabavi SF, Latifi AM, Moghaddam AH, Hellio C. Neuroprotective effects of silymarin on sodium fluoride-induced oxidative stress. Journal of Fluorine Chemistry 2012;142:79-82. [DOI: 10.1016/j.jfluchem.2012.06.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
122 Tewari-Singh N, Jain AK, Inturi S, Agarwal C, White CW, Agarwal R. Silibinin attenuates sulfur mustard analog-induced skin injury by targeting multiple pathways connecting oxidative stress and inflammation. PLoS One 2012;7:e46149. [PMID: 23029417 DOI: 10.1371/journal.pone.0046149] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
123 Tewari-Singh N, Jain AK, Inturi S, Ammar DA, Agarwal C, Tyagi P, Kompella UB, Enzenauer RW, Petrash JM, Agarwal R. Silibinin, dexamethasone, and doxycycline as potential therapeutic agents for treating vesicant-inflicted ocular injuries. Toxicol Appl Pharmacol 2012;264:23-31. [PMID: 22841772 DOI: 10.1016/j.taap.2012.07.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
124 Lu W, Lin C, King TD, Chen H, Reynolds RC, Li Y. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells. Cell Signal 2012;24:2291-6. [PMID: 22820499 DOI: 10.1016/j.cellsig.2012.07.009] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 7.2] [Reference Citation Analysis]
125 Cho J, Park JW, Song S. Injectable and Biodegradable Poly(Organophosphazene) Gel Containing Silibinin: Its Physicochemical Properties and Anticancer Activity. Journal of Pharmaceutical Sciences 2012;101:2382-91. [DOI: 10.1002/jps.23137] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
126 Yousefi M, Ghaffari SH, Soltani BM, Nafissi S, Momeny M, Zekri A, Behmanesh M, Alimoghaddam K, Ghavamzadeh A. Therapeutic Efficacy of Silibinin on Human Neuroblastoma Cells: Akt and NF-κB Expressions May Play an Important Role in Silibinin-Induced Response. Neurochem Res 2012;37:2053-63. [DOI: 10.1007/s11064-012-0827-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
127 Shrotriya S, Gagan D, Ramasamy K, Raina K, Barbakadze V, Merlani M, Gogilashvili L, Amiranashvili L, Mulkijanyan K, Papadopoulos K, Agarwal C, Agarwal R. Poly[3-(3, 4-dihydroxyphenyl) glyceric acid] from Comfrey exerts anti-cancer efficacy against human prostate cancer via targeting androgen receptor, cell cycle arrest and apoptosis. Carcinogenesis 2012;33:1572-80. [PMID: 22693258 DOI: 10.1093/carcin/bgs202] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
128 Zhang Y, Li Q, Ge Y, Chen Y, Chen J, Dong Y, Shi W. Silibinin Triggers Apoptosis and Cell-Cycle Arrest of SGC7901 Cells: SILIBININ CELL-CYCLE ARREST SGC7901. Phytother Res 2013;27:397-403. [DOI: 10.1002/ptr.4733] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
129 Wassermann R, Novik V, Danilenko M. Cell-Type-Specific Effects of Silibinin on Vitamin D-Induced Differentiation of Acute Myeloid Leukemia Cells Are Associated with Differential Modulation of RXRα Levels. Leuk Res Treatment 2012;2012:401784. [PMID: 23259067 DOI: 10.1155/2012/401784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
130 Zhang Y, Ge Y, Chen Y, Li Q, Chen J, Dong Y, Shi W. Cellular and molecular mechanisms of silibinin induces cell-cycle arrest and apoptosis on HeLa cells. Cell Biochem Funct 2012;30:243-8. [PMID: 22170400 DOI: 10.1002/cbf.1842] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
131 Roy S, Deep G, Agarwal C, Agarwal R. Silibinin prevents ultraviolet B radiation-induced epidermal damages in JB6 cells and mouse skin in a p53-GADD45α-dependent manner. Carcinogenesis 2012;33:629-36. [PMID: 22166495 DOI: 10.1093/carcin/bgr299] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
132 Dizaji MZ, Malehmir M, Ghavamzadeh A, Alimoghaddam K, Ghaffari SH. Synergistic Effects of Arsenic Trioxide and Silibinin on Apoptosis and Invasion in Human Glioblastoma U87MG Cell Line. Neurochem Res 2012;37:370-80. [DOI: 10.1007/s11064-011-0620-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
133 Gažák R, Valentová K, Fuksová K, Marhol P, Kuzma M, Medina MÁ, Oborná I, Ulrichová J, Křen V. Synthesis and antiangiogenic activity of new silybin galloyl esters. J Med Chem 2011;54:7397-407. [PMID: 21928794 DOI: 10.1021/jm201034h] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
134 Ge Y, Zhang Y, Chen Y, Li Q, Chen J, Dong Y, Shi W. Silibinin causes apoptosis and cell cycle arrest in some human pancreatic cancer cells. Int J Mol Sci 2011;12:4861-71. [PMID: 21954330 DOI: 10.3390/ijms12084861] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
135 Tang N, Xie Q, Wang X, Li X, Chen Y, Lin X, Lin J. Inhibition of invasion and metastasis of MHCC97H cells by expression of snake venom cystatin through reduction of proteinases activity and epithelial-mesenchymal transition. Arch Pharm Res. 2011;34:781-789. [PMID: 21656364 DOI: 10.1007/s12272-011-0512-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
136 Amado NG, Fonseca BF, Cerqueira DM, Neto VM, Abreu JG. Flavonoids: potential Wnt/beta-catenin signaling modulators in cancer. Life Sci. 2011;89:545-554. [PMID: 21635906 DOI: 10.1016/j.lfs.2011.05.003] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
137 Deep G, Gangar SC, Agarwal C, Agarwal R. Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells. Cancer Prev Res (Phila) 2011;4:1222-32. [PMID: 21546539 DOI: 10.1158/1940-6207.CAPR-10-0370] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
138 Wang X, Gocek E, Novik V, Harrison JS, Danilenko M, Studzinski GP. Inhibition of Cot1/Tlp2 oncogene in AML cells reduces ERK5 activation and up-regulates p27Kip1 concomitant with enhancement of differentiation and cell cycle arrest induced by silibinin and 1,25-dihydroxyvitamin D(3). Cell Cycle 2010;9:4542-51. [PMID: 21084834 DOI: 10.4161/cc.9.22.13790] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
139 Khakinezhad Tehrani F, Ranji N, Kouhkan F, Hosseinzadeh S. PANC-1 cancer stem-like cell death with silybin encapsulated in polymersomes and deregulation of stemness-related miRNAs and their potential targets. Iran J Basic Med Sci 2021;24:514-23. [PMID: 34094034 DOI: 10.22038/ijbms.2021.54001.12136] [Cited by in F6Publishing: 1] [Reference Citation Analysis]